FDA panel recommends CBD for pediatric seizure disorders
By Kari Oakes | Clinical Neurology News | REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING Advisors to the Food and Drug Administration have found a generally favorable benefit-risk profile for cannabidiol oil solution in the treatment of two forms of severe pediatric seizure disorders. The drug is under expedited review by the agency.In a unanimous…
Details